This topic contains a solution. Click here to go to the answer

Author Question: A pt. undergoing chemotherapy is most likely going to experience GI problems because: a. the ... (Read 83 times)

jho37

  • Hero Member
  • *****
  • Posts: 531
A pt. undergoing chemotherapy is most likely going to experience GI problems because:
 a. the chemotherapeutic agents are difficult to metabolize.
  b. the chemotherapeutic agents are given systemically and affect the rapidly-dividing epithelial cells that line the GI system.
  c. the chemotherapeutic agents cause an allergic reaction.
  d. the chemotherapeutic agents are so strong they cause hemorrhaging.

Question 2

Patients with cancer cachexia may experience muscle wasting due to:
 a. hypercatabolism and/or decreased protein synthesis.
  b. anorexia and/or nausea.
  c. hypocatabolism and/or increased protein synthesis.
  d. blood loss and/or hemorrhaging.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Andromeda18

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

b

Answer to Question 2

a




jho37

  • Member
  • Posts: 531
Reply 2 on: Aug 20, 2018
Excellent


amandalm

  • Member
  • Posts: 306
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

Many supplement containers do not even contain what their labels say. There are many documented reports of products containing much less, or more, that what is listed on their labels. They may also contain undisclosed prescription drugs and even contaminants.

Did you know?

Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

The FDA recognizes 118 routes of administration.

For a complete list of videos, visit our video library